Cargando…
Current Pharmacological Advances in the Treatment of Cardiac Arrest
Cardiac arrest is defined as the sudden cessation of spontaneous ventilation and circulation. Within 15 seconds of cardiac arrest, the patient loses consciousness, electroencephalogram becomes flat after 30 seconds, pupils dilate fully after 60 seconds, and cerebral damage takes place within 90–300...
Autores principales: | Papastylianou, Andry, Mentzelopoulos, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226361/ https://www.ncbi.nlm.nih.gov/pubmed/22145080 http://dx.doi.org/10.1155/2012/815857 |
Ejemplares similares
-
Vasopressin, epinephrine, and methylprednisolone in inhospital cardiac arrest
por: Mentzelopoulos, S, et al.
Publicado: (2007) -
General Critical Care, Temperature Control, and End-of-Life Decision Making in Patients Resuscitated from Cardiac Arrest
por: Chalkias, Athanasios, et al.
Publicado: (2023) -
Possible significance of hemodynamic and immunomodulatory effects of early stress-dose steroids in cardiac arrest
por: Mentzelopoulos, Spyros D., et al.
Publicado: (2016) -
Recent advances in personalizing cardiac arrest resuscitation
por: Kuschner, Cyrus E., et al.
Publicado: (2019) -
Use of Sodium Bicarbonate in Cardiac Arrest: Current Guidelines and Literature Review
por: Velissaris, Dimitrios, et al.
Publicado: (2016)